Table 4.
Prevalence of post COVID-19 condition in the Omicron group and the control group.
| Symptomsa | Omicron group (n = 18) | Control group (n = 18) | p-valueb |
|---|---|---|---|
| Fatigue | 1 (5.6) | 1 (5.6) | 1.0 |
| SoB | 0 (0.0) | 1 (5.6) | 1.0 |
| Cough | 0 (0.0) | 3 (16.7) | 0.229 |
| Dysosmia | 0 (0.0) | 3 (16.7) | 0.229 |
| Dysgeusia | 0 (0.0) | 1 (5.6) | 1.000 |
| Hair loss | 0 (0.0) | 3 (16.7) | 0.229 |
| Depressed mood | 0 (0.0) | 0 (0.0) | 1.0 |
| Brain fog | 0 (0.0) | 1 (5.6) | 1.0 |
| LoC | 0 (0.0) | 1 (5.6) | 1.0 |
| MD | 0 (0.0) | 2 (11.1) | 0.486 |
| At least one post COVID-19 condition | 1 (5.6) | 10 (55.6) | 0.003 |
Abbreviations: SoB, shortness of breath; LoC, loss of concentration; MD, memory disturbance.
a
Definition of post COVID-19 condition is a symptom that last at least 2 months within 3 months since the onset of COVID-19.
b
Results of Fisher's exact test.